European VC Funds

OTB Ventures is a European venture capital firm based in Amsterdam, focused on deep tech startups across Central and Eastern Europe. They specialize in sectors like space tech, artificial intelligence, automation, fintech, and cybersecurity. Founded by Adam Niewinski and Marcin Hejka, OTB Ventures aims to support founders with unique IP and global ambitions by providing early growth funding. Their portfolio includes notable companies like ICEYE, which specializes in radar satellite imagery; Silent Eight, an AI platform for financial crime detection; and Fractory, an automated on-demand metal manufacturing platform. Other significant investments include Turnkey Lender, an embedded lending platform, and Hydrosat, which provides thermal infrared imagery for analytics. OTB Ventures supports their portfolio companies with business and partner introductions, expertise in sales channels, and strategic guidance for international expansion. They are also involved in syndicating additional financing and preparing companies for successful exits.

OurCrowd, founded in 2013 and headquartered in Jerusalem, is a leading global venture capital platform. It offers accredited investors access to pre-vetted startups, exclusive venture funds, and alternative investments. The firm’s portfolio covers sectors such as healthcare, AI, robotics, energy, and fintech, with notable investments in Beyond Meat, JumpCloud, and Lemonade. Beyond Meat, a leader in plant-based foods, and Lemonade, an AI-driven insurance company, both had successful IPOs and continue to thrive. OurCrowd’s investment strategy involves thorough due diligence and active support for portfolio companies, ranging from seed to growth stages. They typically invest between $1 million and $5 million, offering strategic guidance and access to a global network of co-investors and operational support​. The firm operates globally, with a strong presence in Israel and the U.S., and investments in Europe, Asia, and Latin America. This global reach allows them to tap into diverse markets and innovative ecosystems. Led by CEO Jon Medved, OurCrowd’s team includes investment professionals across multiple offices worldwide, ensuring a comprehensive approach to emerging technologies and market opportunities. Startups seeking investment should highlight their innovation, scalability, and market potential, approaching OurCrowd through their network or platform to increase funding chances

Outsized Ventures is a venture capital fund based in London, specializing in deep tech and frontier technology startups that aim to tackle the world's most pressing challenges. The fund takes a unique approach by prioritizing people over technology, focusing on bold innovators who are not afraid to push boundaries. Notable investments include companies like Emitwise (carbon accounting software), Hoxton Farms (cultivated fat for meat alternatives), and Kernal Biologics (mRNA therapeutics), reflecting their commitment to groundbreaking science and technology. Outsized Ventures primarily invests in Europe, with a clear focus on early-stage ventures. Their strategy is founder-friendly, offering quick, transparent investment processes, sometimes closing deals within 48 hours. They often invest between fundraising rounds, helping founders maintain momentum without the distraction of constant fundraising. The team is led by experienced investors like Max, a former corporate lawyer and venture capitalist with extensive experience across Europe, Africa, and Asia, and Rod, a seasoned investor with a strong background in bioengineering startups. Outsized Ventures typically leads funding rounds and is known for offering "clean and unfussy" terms, making them an attractive partner for ambitious entrepreneurs aiming to make a significant impact. If you’re a visionary founder with a big dream, they’re the kind of investor who will back you all the way.

Outward VC is a London-based early-stage venture capital firm founded in 2017 by Co-Founders and General Partners Kevin Chong and Devin Kohli. Originally launched as the Outward Venture Capital Fund of Investec Bank, the firm has since grown into an independent platform dedicated to fintech and adjacent sectors, including healthcare, education, property, legal services, AI, and insurance. Outward's thesis holds that fintech extends well beyond traditional financial services and that the future of finance is more open, embedded, and intertwined with society-shifting challenges. The firm typically leads rounds up to GBP 5 million, investing at least 50 percent of the round, and reserves significant follow-on capital for portfolio companies. Outward leads rounds at pre-Series A stage and has backed approximately 100 founders to date. Portfolio highlights include Bud ($80 million Series B), Curve (GBP 133 million Series C), Peppy Health ($45 million Series B), Vauban (acquired by Carta), Clearglass, Exate, Orbital Witness, and Supercede. In September 2024 the firm announced the GBP 51 million first close of Fund II, anchored by a GBP 30 million cornerstone from the British Business Bank's Enterprise Capital Funds programme, with a target of GBP 100 million at second close. Recent Fund II investments include a GBP 2.5 million Seed round into Lombard-lending fintech Firenze in March 2025 and Steward AI in March 2026. Outward VC combines high conviction with meaningful ownership, taking a concentrated approach that allows it to dedicate real time and resource to each portfolio company. The firm's roots in the Investec network and its close relationship with the British Business Bank give founders access to institutional financial relationships alongside hands-on operating support.

Overkill Ventures, founded in 2017 and based in Riga, Latvia, is an angel fund that focuses on pre-seed investments in B2B technology startups across the Baltics, Nordics, Central Eastern Europe (CEE), and Commonwealth of Independent States (CIS). The firm emphasizes helping startups achieve product-market fit and scale their operations. Overkill Ventures has made 38 investments, with notable investments in companies like Paul-Tech, WeedBot, and MediNav. The firm is led by General Partners David Ventzel, Peter Marculans, and Dmitry Saikovsky, who bring extensive experience from startup accelerators and M&A activities. While Overkill Ventures is currently not making new investments directly, they continue to support early-stage startups through their sister funds, Accelerace and New Nordic Ventures.

Overwater Ventures is an early-stage venture capital firm based in San Francisco, founded and led by Kristina Simmons, a former partner at Andreessen Horowitz and Chief of Staff at Khosla Ventures. The firm focuses on investing in breakthrough technologies that positively impact human health and the planet. Overwater Ventures closed its $20 million debut fund in April 2023, with backing from institutional family offices, experienced founders, and prominent investors like Vinod Khosla. The fund primarily targets sectors such as digital health, biotech, AI, robotics, climate tech, and future food. Notable portfolio companies include Overstory, which reduces power outages and wildfires, and Conceive, a fertility technology firm. Overwater Ventures is committed to providing holistic support to its founders, addressing not just business needs like marketing and fundraising but also personal well-being, including mental health and stress management.

OVNI Capital is a Paris-based early-stage venture capital firm that specializes in backing tech-driven startups with global ambitions. Launched in 2022, OVNI primarily focuses on sectors such as fintech, cybersecurity, AI, climate tech, and food tech. They typically invest in French companies but are open to international expansion, supporting founders as they scale globally from day one. Notable investments include companies like FairMoney, Umiami, and OnOff, showcasing their commitment to transformative technologies. With a strategy centered around first-check investments, OVNI commits early, with typical check sizes ranging from €250K to €3M. The firm is also known to lead rounds and continue backing its portfolio through later stages. OVNI is driven by a highly operational approach, offering hands-on support through their network of operating partners who bring international market expertise. The team is led by General Partners Arnaud Laurent and Augustin Sayer, who emphasize the importance of early internationalization and differentiation through advanced technology. OVNI is actively shaping its portfolio to reflect the future of disruptive tech and stands out for its proactive, founder-friendly approach to venture capital.

Oxford Capital Partners, founded in 1999 and based in Oxford, UK, is a venture capital firm that focuses on investing in early-stage technology companies. The firm has invested approximately £500 million in over 100 businesses, emphasizing sectors such as fintech, digital health, artificial intelligence, and the future of retail. Their investment strategy leverages the UK's Enterprise Investment Scheme (EIS), providing tax advantages to investors and fostering innovation across the tech landscape. Oxford Capital seeks to back high-potential, disruptive technology with strong intellectual property or early signs of product-market fit. They typically aim to be the first institutional investor in these early-stage ventures, ranging from seed to Series A rounds. Their portfolio includes notable companies like Moneybox, Red Sift, and Attest. The firm prides itself on a hands-on approach, supporting founders with not only capital but also strategic guidance to help them achieve significant growth and scalability. The team, led by founder David Mott and including key members like Stephen Hampson and Chris Payne, brings a wealth of experience in venture capital and strategic investments. Oxford Capital's location in one of the world's leading knowledge clusters, Oxford, positions them advantageously to tap into cutting-edge innovations and support high-growth companies aiming to expand internationally.

Oxford Science Enterprises (OSE), previously known as Oxford Sciences Innovation, is a prominent investment company founded in 2015 with the mission to commercialize the cutting-edge research from the University of Oxford. OSE has raised over £850 million and invested around £775 million into over 45 core portfolio companies across three main sectors: Deep Tech, Life Sciences, and Health Tech. Notable investments include Vaccitech, the developer of the Oxford-AstraZeneca COVID-19 vaccine, Quantum Motion, and Beacon Therapeutics, which is advancing gene therapies for retinal diseases. OSE typically provides the first cheque to early-stage companies and supports them all the way to exit. Their strategy involves deep collaboration with Oxford University, leveraging the university's vast research capabilities to create transformative businesses. This partnership has resulted in over £1.4 billion in investment into university spinouts as of 2021, significantly increasing the scale and impact of Oxford's innovation ecosystem. The firm is committed to addressing some of the world's most significant challenges by supporting pioneering technologies and translating novel research into real-world applications. Their hands-on approach includes taking board seats and actively engaging with the founding teams to provide strategic guidance and operational support.

Oxford Technology is a venture capital firm that specializes in investing in early-stage technology-based businesses. They manage both SEIS (Seed Enterprise Investment Scheme) and EIS (Enterprise Investment Scheme) funds, providing up to £150k in seed funding for SEIS companies and up to £300k in follow-on funding for EIS companies. Their focus is on science, technology, and engineering startups, primarily within a 60-mile radius of Oxford to facilitate active involvement with the companies. Notable investments by Oxford Technology include OxWash, which is developing sustainable laundry solutions; Refeyn, pioneering mass photometry for single molecules; and HydRegen, creating bio-based manufacturing technologies. They have also invested in innovative companies like Neuroute, which aggregates data for clinical trial recruitment, and Covatic, enabling personalized content creation without the need for tracking IDs. Oxford Technology aims to maximize shareholder value by working closely with their portfolio companies to achieve successful exits and providing ongoing support. Their investment strategy not only leverages tax reliefs but also focuses on creating successful companies with significant long-term growth potential.

Oxx VC is a venture capital firm specializing in B2B SaaS investments, focusing on scale-up stage companies in Europe and Israel. Founded in 2017, Oxx operates from London and Stockholm, providing essential growth capital and strategic resources to help companies achieve explosive growth. Notable investments by Oxx include Peak, a SaaS company leveraging AI for decision intelligence; Funnel, which offers marketing data hub solutions; and Codility, a platform for technical hiring. These investments highlight Oxx's commitment to supporting innovative software companies that have achieved product-market fit and are ready to scale. Oxx recently closed its second fund at €172 million, backed by institutional investors such as British Patient Capital, Saminvest, KfW Capital, and Argentum. This fund will continue to support SaaS companies through growth stages, particularly those focusing on AI-driven innovations. The firm, led by co-founders Richard Anton and Mikael Johnsson, prides itself on a selective, evidence-based investment approach, providing tailored support to each portfolio company. Oxx's mission is to help build global category leaders in the SaaS sector by combining deep industry knowledge, a strong network, and hands-on partnership.

Oyster Bay Venture Capital is a Hamburg-based early-stage venture capital firm founded in 2018 by Managing Partners Felix Leonhardt and Christoph Miller, who brings more than 25 years of senior food-industry experience. The firm is one of Europe's largest dedicated food-systems venture capital funds, operating under the thesis that the way we nourish ourselves defines our future. Oyster Bay invests sector-agnostically across the entire food value chain, from agtech and novel ingredients to consumer brands, manufacturing robotics, and food waste reduction, taking lead positions at seed and Series A with initial checks of EUR 1 million to EUR 5 million and a two-year follow-on commitment covering roughly the next two rounds. In November 2025 Oyster Bay closed its oversubscribed Fund II at over EUR 100 million, backed by the European Investment Fund and KfW, targeting approximately 20 portfolio investments. Fund I, which delivered reported net annual returns above 25 percent, backed early-stage companies including Oatly, air up, True Gum, La Vie, Dropz, Hooked, Peas of Heaven, and purefood. Early Fund II deployments include a lead $5.25 million Series A into Arda Biomaterials (with Green Angel Ventures and Clean Growth Fund), GoodBytz (kitchen robotics), Nukoko (alternative cocoa), and Seedalive (seed-testing technology). The firm has made 14 investments across its two funds. Oyster Bay operates with a 13-person team and brings together financial capital with a deep network of food-industry executives, retailers, and ingredient specialists. Its combination of market-specific expertise and EU institutional backing makes it a sought-after partner for founders disrupting food production, distribution, and consumption across Europe.

P101 Ventures, founded in 2013 and based in Milan, Italy, is a venture capital firm focusing on early-stage investments in the digital and technology sectors. With over 100 million euros under management, P101 is known for its commitment to nurturing innovative startups through capital, extensive networks, and strategic advisory. P101’s portfolio includes a variety of successful companies such as Tannico, an e-commerce platform for wine; BorsadelCredito.it, a peer-to-peer lending platform; and Cortilia, an online marketplace for fresh, local food products. The firm typically invests between 1 to 5 million euros per company and reserves additional capital for follow-on investments to support the continued growth of its portfolio companies. The firm's investment strategy involves active collaboration with founders, helping them design effective growth strategies and improve their ESG performance. P101 also leverages a strong network of strategic consultants, CEOs, and industry experts to provide deep operational and business development support​.

Pale Blue Dot is a venture capital firm based in Malmö, Sweden, focused on early-stage investments in climate tech startups. Founded in 2020 by Joel Larsson, Heidi Lindvall, and Hampus Jakobsson, the firm aims to back founders addressing one of the most pressing global challenges: climate change. Pale Blue Dot invests in seed and pre-seed stage companies, typically with ticket sizes ranging from €500,000 to €2 million. They target businesses that offer scalable, innovative solutions to mitigate or reverse the effects of climate change. The firm’s portfolio spans diverse sectors, including foodtech, agtech, energy, logistics, and biotech, with notable investments in companies such as Monta, Hived, and Overstory. Their strategy involves leading or co-leading rounds, with a focus on companies based in Europe and the US. Pale Blue Dot has two funds: Fund I (€87 million) and Fund II (€93 million), demonstrating their commitment to investing in businesses that not only turn a profit but also have a significant, positive environmental impact. The fund places a strong emphasis on diversity and inclusion, aiming to back visionary leaders building sustainable and equitable companies. Their mission is to invest in technologies that will shape a future where every business operates as a net positive for the planet, aligning profit with impact. Pale Blue Dot views the climate crisis not just as a challenge, but as an opportunity to build the next generation of billion-dollar companies driving real-world change.

Palm Drive Capital, headquartered in New York City with additional offices in San Francisco and Taipei, is a venture capital firm that specializes in early-stage investments. Founded in 2014, the firm primarily backs Seed and Series A tech founders across SaaS, AI, fintech, and e-commerce sectors. Their global approach underscores their belief that "innovators are everywhere," supporting startups from diverse geographical regions​. The firm has a notable portfolio, including investments in Deep Instinct, a leader in cybersecurity, and MoneyLion, a modern challenger bank. Palm Drive Capital has also achieved significant exits, such as those from Clover Health and Long Game, highlighting their success in identifying and nurturing high-potential startups​. Palm Drive Capital prefers a collaborative investment approach, frequently co-investing with other venture firms rather than leading rounds. Their strategy focuses on scalable solutions in high-growth markets, providing not only financial support but also strategic guidance through their extensive network. This approach has positioned them as a valuable partner for early-stage companies looking to scale efficiently. Led by co-founders Hendrick Lee and Seamon Chan, the team comprises experts like Catherine Cai and Nick Hsu, who contribute significant investment and operational expertise. For startups aiming to engage with Palm Drive Capital, demonstrating a robust product-market fit and a clear scalability plan is crucial. The firm values well-prepared pitches that highlight market opportunities and strategic growth plans​.

Panacea Stars is a UK-based venture capital firm specializing in healthcare and life sciences startups. Founded in Oxford, Panacea Stars provides a multi-phase framework to support the development of early-stage scientific ventures, focusing on de-risking and accelerating their growth from ideation to market launch. Over the past six years, Panacea Stars has supported over 250 startups, many of which have secured significant seed funding and are now valued at around £1 billion collectively. Their portfolio includes notable companies such as DJS Antibodies, acquired by AbbVie; Enterobiotix, which has raised over £20 million; and Phenomic AI, which has secured approximately $10 million. Panacea Stars offers comprehensive mentorship, access to industry experts, and tailored support through their programs. They host bootcamps, demo days, and provide non-dilutive funding to help startups refine their business models and strategies. Panacea Stars also emphasizes collaboration with academic and corporate partners to provide startups with a robust support network. The firm operates primarily in the UK but has a global outlook, aiming to nurture the next generation of health and life science innovators.

Panacea Venture is a global healthcare-focused venture capital fund with a strong track record in early-stage life sciences investments. Spun out of Kleiner Perkins, Panacea specializes in building innovative companies that target unmet medical needs, particularly in biotech, therapeutics, and medical devices. Their investment scope spans cell and gene therapies, diagnostics, and emerging technologies like AI-driven healthcare solutions. With a global reach, Panacea has offices in Shanghai, Boston, and Silicon Valley, leveraging its cross-border expertise to tap into transformative healthcare innovations across North America and Asia. The firm is highly active, leading early-stage rounds and often taking board seats, while its venture operator model allows them to incubate and actively manage portfolio companies. Notable portfolio names include groundbreaking companies in immunotherapy and gene editing, such as TriArm Therapeutics and Kindstar Global. Panacea’s investment approach focuses on deep due diligence and long-term partnerships. They seek companies with strong scientific foundations and scalable technologies, preferring founders with deep domain expertise. The fund’s managing partner, James Huang, along with a diverse team of venture partners, brings over 100 years of combined experience in both venture capital and life sciences industries. They continue to focus on early-stage growth, with an emphasis on hands-on involvement to drive value from inception to public market success.

Panakès Partners, based in Milan, is a leading venture capital firm specializing in life sciences. Founded by Diana Saraceni, who has over 20 years of experience in the VC industry, the firm focuses on early-stage startups and SMEs developing innovative technologies in biotech, diagnostics, and medical devices. Their portfolio includes notable investments like EndoStart and Diadem, reflecting their commitment to groundbreaking solutions in healthcare. Panakès primarily targets Europe and Israel, aiming to address significant unmet medical needs with a robust ESG framework. Their latest €175 million fund, the Purple Fund, emphasizes Series A investments, supporting around 15-18 companies with average checks ranging from €5 to €10 million. Known for leading rounds, Panakès actively engages with startups through a rigorous selection process, valuing sustainability and impactful health solutions. The team, led by Saraceni, brings extensive expertise and a strong network in the life sciences sector, bolstered by their participation in various national and international advisory boards. For entrepreneurs, Panakès is approachable via direct submissions to their email, fostering a transparent and accessible investment process.

Pantera Capital is a pioneering venture capital firm focused exclusively on blockchain and cryptocurrency investments. Founded by Dan Morehead in 2003, Pantera launched the first cryptocurrency fund in the U.S. in 2013 when Bitcoin was valued at $65 per BTC. They have since introduced various funds, including the first blockchain-focused venture fund and the first early-stage token fund in 2017. Pantera manages $5.6 billion in assets, providing investors with comprehensive exposure to the blockchain ecosystem through venture equity, early-stage tokens, and liquid tokens. Their investment strategy is global, having backed over 100 blockchain companies and 110 early-stage token deals across sectors like decentralized finance (DeFi), next-gen payment systems, and institutional trading tools. The firm's notable funds include the Pantera Venture Funds, Pantera Bitcoin Fund, Pantera Liquid Token Fund, and the all-encompassing Pantera Blockchain Fund. Their extensive portfolio features key players in the blockchain space, contributing significantly to the industry's infrastructure and growth. Pantera Capital operates from offices in the Bay Area, New York, and Puerto Rico, with a team of seasoned professionals bringing decades of experience from top-tier financial firms and technical backgrounds.

Paradigm Ventures is a prominent venture capital firm that excels in investing within the cryptocurrency and blockchain technology sectors. Their portfolio boasts notable investments such as Coinbase, Chainalysis, and OpenSea, reflecting their strong presence in the digital assets space. They focus on investing in early-stage ventures but also support companies through various growth stages with investment sizes ranging from $1M to $100M. Paradigm's investment strategy is deeply research-driven, often leading rounds and providing significant hands-on support in areas like technical mechanism design, smart contract security, and operational scaling. This approach not only ensures the technological robustness of their portfolio companies but also aids in achieving long-term growth and market leadership. Geographically, Paradigm is heavily invested in the United States, particularly within major tech hubs such as San Francisco. However, their investments and interest span globally, targeting innovative companies that push the boundaries of blockchain technology. Paradigm prefers to be approached by startups with a clear and compelling vision for their technology and its impact on the crypto ecosystem. They are highly selective, looking for teams with strong technical foundations and a demonstrated ability to execute their vision effectively.

Pario Ventures is a UK-based early-stage venture capital firm founded in 2010 by CEO and Co-Founder David Murray-Hundley and Co-Founder Kevin Doyle, headquartered on the Isle of Wight in Cowes. The firm backs founders and early-stage companies worldwide from seed through Series A and beyond, offering capital, strategic advice, and real-world operational support. Pario has approximately GBP 45 million available to deploy, with a typical check size of around $2 million within a $1 million to $10 million range, allowing it to lead smaller rounds or co-invest in larger ones. Brand, marketing, and communications strategist Trina Murray-Hundley leads operational support for portfolio companies. The firm received the 2024 Private Equity and Venture Capital Award from Wealth and Finance International. Pario leads rounds and has made more than 110 investments, with the firm's own site claiming over 140 portfolio companies, spanning automotive and mobility, hospitality, fintech, payments, blockchain, software, technology, and communications. Named portfolio companies include Axonyz.ai (commercial AI products, most recent investment in October 2025), Pario Azure (cloud services), and SWOP, a UK-based peer-to-peer blockchain-powered marketplace for trusted trading of physical and digital items. The firm co-invests across European and US-based startups. Pario Ventures takes a hands-on approach to portfolio engagement, with operational support extending well beyond board-level governance. Its founding team's background in building and scaling businesses provides founders with practitioner-grade advice on commercial strategy, brand positioning, and fundraising, particularly relevant for early-stage companies navigating growth across multiple geographies.

Parkwalk Advisors, founded in 2009, is a leading UK-based growth fund manager specializing in investments in university spin-outs. With over £500 million raised and investments in more than 180 companies, Parkwalk focuses on high-growth, knowledge-intensive sectors such as AI, big data, life sciences, cleantech, and quantum computing. Parkwalk's notable portfolio companies include Bramble Energy, a clean energy technology provider; AccelerComm, a semiconductor chip design company; and PetMedix, a veterinary biopharmaceutical company. These investments highlight Parkwalk's commitment to fostering innovation in deep tech and science sectors. The firm manages various funds, including the Parkwalk Opportunities EIS Fund and the Knowledge Intensive EIS Funds, which offer tax benefits under the Enterprise Investment Scheme (EIS). These funds aim to support the commercialization of technologies emerging from the UK's top universities, such as Oxford, Cambridge, Imperial College, and UCL. Parkwalk's approach to investing includes providing strategic support and leveraging their extensive network to help portfolio companies achieve their full potential. They have been the largest single EIS fundraise for several years, demonstrating their pivotal role in the UK’s venture capital landscape.

Partech is a global venture capital firm with a strong focus on technology startups, operating across several investment stages—Seed, Venture, Growth, and Impact. Its portfolio includes notable companies such as Akeneo, a leader in product information management, and ManoMano, Europe's top online marketplace for DIY and gardening products. With offices in San Francisco, Paris, Berlin, and Dakar, Partech invests worldwide, with a special focus on Europe and Africa. The firm’s seed-stage investments typically range from €300k to €3M, with Partech taking a hands-on approach to support startups from the earliest stages. In the growth phase, they invest larger amounts—up to €100M—to scale high-growth companies like Rohlik Group, a rapidly expanding online grocery delivery service. Partech also leads the way in African tech investments, backing companies such as Wave Sénégal, a leading mobile money provider. Their impact fund focuses on scaling companies addressing environmental and social challenges, with investments ranging from €15M to €40M.

Pascual Innoventures is the corporate venturing arm of the Pascual Group, dedicated to investing in innovative startups within the food and agriculture sectors. With a focus on disrupting traditional food systems, they target areas like alternative proteins, food tech, and agritech. The firm is particularly interested in technologies that promote sustainability and improve human health, such as precision fermentation and functional ingredients. Their portfolio includes startups like Zero Cow Factory, which develops dairy proteins using fermentation, and DeNovo Foodlabs, which focuses on nutrition solutions. Pascual Innoventures also runs "Mylkcubator," the world’s first incubator focused on dairy industry innovation, supporting startups in cellular agriculture and fermentation technologies. The fund offers more than just capital by providing startups with extensive operational support, including marketing, HR, and legal assistance, as well as access to R&D facilities. Led by Gabriel Torres Pascual, a third-generation member of the Pascual family, the firm aims to create long-term impact by nurturing startups from concept to market.

Passion Capital, founded in 2011 and based in London, is a prominent early-stage venture capital firm focusing on technology startups. The firm was established by Eileen Burbidge, Robert Dighero, and Stefan Glaenzer, all successful entrepreneurs. Passion Capital is known for its hands-on approach, providing not only funding but also mentorship and strategic advice to its portfolio companies. Passion Capital has a strong track record of backing successful startups, including well-known names like Monzo, the digital bank; GoCardless, a payment processing company; and Lendable, a platform for personal loans. They invest primarily in sectors such as information technology, TMT (Technology, Media, and Telecommunications), IoT (Internet of Things), mobile, infrastructure, and SaaS (Software as a Service) within Europe. The firm typically invests in companies at the seed stage and often leads the funding rounds. Their investment philosophy emphasizes a strong relationship with founders, aiming to support and guide them through the early challenges of scaling their businesses. The founding partners bring extensive experience and have been instrumental in shaping Europe's technology landscape. Passion Capital also made headlines by opening up part of their latest £45 million fund to retail investors via crowdfunding, a first for a European VC firm. This innovative approach reflects their commitment to democratizing access to venture capital investments.

Paua Ventures, now rebranded as SquareOne, is a Berlin-based venture capital firm that focuses on pre-seed and seed-stage investments. Established in 2010, SquareOne primarily backs B2B tech startups, emphasizing sectors like SaaS, deep tech, and enterprise software. The firm is often the first institutional investor on the cap table, acting as a strategic partner for founders throughout the company's early development stages. SquareOne is known for offering more than just capital. The firm prides itself on being a hands-on partner, providing operational support, mentorship, and valuable connections within its extensive network of executives and industry experts. This proactive involvement helps founders navigate the complexities of scaling their businesses, and many of SquareOne’s portfolio companies go on to secure follow-on funding from top-tier European and U.S. investors. The firm has a strong track record, with notable investments including Pipedrive, Stripe, and Lesara. SquareOne typically invests in European startups but has a global outlook, supporting innovative companies that have the potential to lead in their industries. Christian Buchenau and Moritz Poewe are among the key partners at SquareOne, guiding the firm’s investment strategy and maintaining its reputation as a leading early-stage investor in Europe. By providing a combination of capital, strategic insight, and market access, SquareOne is positioned as a vital player in the European venture capital landscape, helping startups reach their full potential.

pd ventures (formerly PDV Inter-Media Venture GmbH) is the corporate venture capital arm of Mediengruppe Pressedruck, the Augsburg-based German media group best known for publishing the Augsburger Allgemeine. Founded in 2009 and headquartered in Augsburg, the firm has invested for more than 15 years in digital media and media-adjacent business models across web services, internet, and mobile applications, with a clear preference for scalable propositions targeting the German DACH market and, selectively, international markets. Founder and Managing Director Renate Dempfle leads the platform alongside Investment Manager Fabio Fiorda. Rather than acting as a pure financial backer, pd ventures explicitly leverages the distribution, reach, and operational synergies of the wider Mediengruppe Pressedruck group where relevant, and offers structures including seed funding, Series A, follow-on, financial investor, media-for-equity, and startup advisory arrangements. The firm has made approximately 20 investments and generated one IPO and eight acquisitions. Notable portfolio and exited companies include Ryte (SaaS content and SEO platform, acquired by Semrush in July 2024 following pd ventures' 2017 investment), Lingoda (online language learning, which had raised $83 million including a $68 million Summit Partners round in April 2021), Asgoodasnew, Spark Networks (IPO), pflege.de, Tausendkind, and Good Hood. pd ventures did not record any new investments in 2025 per public sources. For digital media and consumer internet founders building for the DACH market, pd ventures offers a combination of patient capital, media-industry expertise, and access to one of southern Germany's most established regional media networks, making it a strategic co-investor rather than a passive financial partner.

PeakBridge VC is a venture capital firm focused on Agri-FoodTech, investing in companies that address major challenges in the global food system. Founded in 2016 and headquartered in Malta, PeakBridge aims to create long-term impact by investing in startups that drive sustainable solutions, improving both environmental and health outcomes across the food chain. The firm’s investment strategy is centered on five key areas: ingredient innovations, alternative protein technologies, food system digitalization, nutrition & health, and alternative farming systems. By investing in these sectors, PeakBridge helps startups scale solutions that tackle issues such as food waste, nutrition deficiencies, and the carbon footprint of food production. Its portfolio includes innovative companies like Standing Ovation (dairy substitutes through microbial fermentation), Vow (cultured meat), and Rival Foods (plant-based protein). PeakBridge operates through its FoodSparks® Seed Fund for early-stage European and Israeli startups, and Growth II Fund for Series A-B investments in Europe, the U.S., and Israel. The firm’s total assets under management exceed $250 million, with significant backing from Edmond de Rothschild Private Equity. As an Article 9 fund under the Sustainable Finance Disclosure Regulation (SFDR), PeakBridge integrates strict ESG principles into its investments, ensuring all portfolio companies contribute to a healthier and more sustainable food system.

Pentech Ventures is a premier venture capital firm headquartered in Edinburgh with a strong presence in London. They specialize in seed and early-stage investments, primarily targeting innovative software companies. Known for their notable exits like FanDuel, Nutmeg, and Maxymiser, Pentech has a reputation for nurturing companies that redefine their industries. Pentech focuses on UK-based startups across various software domains, including fintech, AI, and SaaS. They typically invest around £1M, often leading rounds and collaborating in syndicates. Their strategy involves not just capital infusion but also strategic guidance, leveraging their extensive network to introduce additional funding partners for subsequent growth stages. The team is led by founding partner Eddie Anderson, alongside experts like Alexander McKinnon and Craig Anderson, all based in Edinburgh. Their deep expertise spans machine learning, enterprise infrastructure, and SaaS business models, providing invaluable support to portfolio companies. For startups seeking investment, Pentech values ambitious leadership and category-defining potential. They prefer to be approached with clear, concise pitches that demonstrate strong market potential and scalability. Active and engaged, Pentech remains a dynamic force in the venture capital landscape, continuously seeking to empower the next generation of software pioneers.

Pfizer Venture Investments (Pfizer Ventures) is the corporate venture capital arm of Pfizer Inc., established in 2004 and headquartered in New York. The platform carries a $900 million total capital commitment, including a $600 million top-up announced in Q4 2021, and backs private companies at all stages of development with a strong bias toward early-stage therapeutics and platform technologies. Investment priorities mirror Pfizer's therapeutic areas: inflammation and immunology, internal medicine, oncology, and neuroscience, extending into platform technologies, diagnostics, drug delivery, pharmaceutical services, and healthcare IT. Roughly 25 percent of available capital, approximately $150 million, is explicitly earmarked for early-stage neuroscience investments. Across approximately 200 investments, Pfizer Ventures has built a concentrated neuroscience portfolio including Aquinnah, Autifony, Cortexyme, MindImmune, Mission Therapeutics, and Neuronetics. The platform leads rounds and invests globally, though deployments skew toward US-based companies. Recent notable investments include Curve Therapeutics (GBP 40.5 million Series A, led in February 2024), Enara Bio ($32.5 million Series B co-led with M Ventures in October 2024), Enlaza Therapeutics ($100 million Series A syndicate in September 2024), OTR Therapeutics ($100 million Series A for a Chinese biotech in June 2025), and Crossbow Therapeutics in March 2026 as the most recent disclosed investment. Pfizer Ventures serves as a strategic window on early-stage innovation across life sciences globally. Portfolio companies benefit not only from capital but also from Pfizer's regulatory expertise, clinical development networks, and therapeutic-area know-how, creating pathways to partnership, licensing, and acquisition that financial-only investors cannot offer.

Phenomen Ventures (Phenomen VC) is a mid-to-late-stage global venture capital firm founded in 2012 and based primarily in London, United Kingdom. The firm describes itself as investing in 'internet and tech phenomenons' — category-leading, fastest-growing companies across the United States, Europe, and Israel. Phenomen focuses on information technology, SaaS, and consumer internet, predominantly at Series A and Series B stages, with particular historical emphasis on Germany-based startups. The firm operates with a lean team of three partners and has more than $300 million in committed capital across 22 investments, with portfolio companies reaching customers in 35 countries. The portfolio carries an enviable track record with two major European consumer-tech IPOs: HelloFresh (listed on Euronext in November 2017 at a $1.91 billion market cap) and Delivery Hero (listed on the Frankfurt Stock Exchange at a $5.01 billion market cap). Four portfolio companies have been acquired in total, including FREE NOW, which was acquired by Lyft for $199 million in April 2025. Other disclosed portfolio companies include Arbox (business and productivity software, most recent investment in September 2025), Constru, Foodpanda, and LightYX. Phenomen Ventures applies a concentrated, conviction-driven approach to identifying category-defining companies at the Series A and B junctures where growth trajectories become apparent but valuations remain constructive. The firm's track record in consumer internet and food technology, combined with its pan-European perspective and US and Israeli deal connectivity, positions it as a specialist partner for founders seeking a globally networked investor with demonstrated success in scaling internet businesses to IPO.

Philips Ventures is the venture capital arm of Royal Philips, focusing on early- to growth-stage investments in healthcare technology startups that align with Philips’ mission to improve patient outcomes, reduce healthcare costs, and transform the healthcare experience. Established in 1998 and based in Amsterdam, Philips Ventures invests globally, supporting companies that develop digital health solutions, medical devices, and health technology services. The fund is business-agnostic but emphasizes sectors like digital software, AI-driven health solutions, and technology-enabled services. Philips Ventures provides not just capital but also strategic support, offering startups access to Philips' extensive clinical and regulatory expertise, global market insights, and deep relationships within the healthcare industry. Their investment strategy includes leading or co-leading rounds, with initial investments typically ranging from $2 million to $5 million, and they actively syndicate deals to collaborate with other investors. Philips Ventures also fosters partnerships between their portfolio companies and Philips' various business units, helping startups scale and navigate the complex healthcare landscape. This approach has led to investments in companies like Elucid, Validic, and MIVI Neuroscience, all of which are pushing the boundaries of healthcare innovation.

Philips Venture Capital Fund (Philips Ventures) is the corporate venture capital arm of Royal Philips, the Dutch multinational health technology company. Founded in 1998 and based in Amsterdam at the Amstelplein 2 Breitner Tower, Philips Ventures deploys strategic capital into early- to growth-stage health technology startups whose innovations complement Philips' global healthcare portfolio and digital transformation agenda. The fund is led by Managing Partner Nate Harrington and operates with a lean two-person team at the fund level. As a corporate and strategic investor, Philips Ventures leverages Philips' deep domain expertise, global commercial footprint, and research and development capabilities to add value to portfolio companies beyond capital alone. Investment activity focuses on Series A and Series B rounds in digital software and technology-enabled healthcare services, predominantly in US-based startups with global activity. The fund has made 22 investments across healthtech, AI, and medical devices and hardware. Notable portfolio companies include PreciseDx (diagnostic equipment, latest investment as part of a Series B-II round in June 2025 as the firm's most recent disclosed deployment), Endovascular Engineering, and R3 Vascular. Recorded exits include Carevive Systems in June 2024 and ALung, acquired by LivaNova in May 2022. The firm currently states it is not investing in development-stage or pre-clinical businesses. Philips Ventures focuses on innovations that can reduce costs, improve clinical outcomes, and transform the patient and clinician experience in ways that align with Philips' strategic roadmap. Portfolio companies benefit from the potential to pilot solutions within Philips' customer network, access the firm's technical talent, and leverage its global healthcare commercial relationships across hospitals, imaging centers, and health systems worldwide.

Phoenix Contact Innovation Ventures (PCIV) is the global corporate venture capital arm of the Phoenix Contact Group, a German industrial technology company specializing in components and systems for electrical connection technology and industrial automation. Founded in 2015 and headquartered in Blomberg, Germany, PCIV identifies, invests in, and scales highly disruptive digital and technology-driven business models that align with Phoenix Contact's vision of a world powered by affordable renewable energy and optimized for industrial energy efficiency. The firm writes initial checks between EUR 0.1 million and EUR 2.5 million and participates in early-stage through second-stage rounds, focusing primarily on European startups. Investment themes include IoT and industrial hardware, industrial SaaS, big data, AI and machine learning, manufacturing technology, electrical connection, industrial automation, and renewable-energy infrastructure. The firm has made 18 disclosed investments over its lifetime, with approximately 10 active portfolio companies as of mid-2025. Notable portfolio companies include aedifion (smart-building SaaS, most recent investment in June 2025 as part of its Series B round in which aedifion raised EUR 17 million to cut real estate costs and CO2 emissions), eologix-ping (wind-turbine blade health monitoring sensors, strategic round in May 2024), and Digital Spine (energy-sector digital platform). PCIV frequently co-invests with Robert Bosch Venture Capital, KfW, and KPN Ventures. Phoenix Contact Innovation Ventures positions itself as a strategic partner that complements capital with access to Phoenix Contact's global industrial and electrical engineering expertise, customer relationships, and supply chain. Founders backed by PCIV gain a corporate partner with deep technical credibility in industrial and energy markets, which can meaningfully accelerate commercial adoption within European infrastructure and manufacturing sectors.

Phoenix Court Group, formerly known as LocalGlobe, is a prominent venture capital firm based in London that has rebranded to reflect its expanded scope and increased funding capacity. The firm has successfully raised $500 million across four distinct funds aimed at supporting tech startups from the seed stage to IPO and beyond. These funds include LocalGlobe, which focuses on pre-seed and seed investments, and Latitude, which targets early growth and Series B/C stages. Additionally, Solar is dedicated to scale-up investments, helping companies transition from private to public markets, while Basecamp supports emerging early-stage funds, angels, and solo general partners across diverse geographies including Africa, Asia Pacific, Europe, India, Israel, and the US​. Phoenix Court Group emphasizes investing in the "New Palo Alto," a term used for the innovation ecosystem in northwest London, particularly in Somers Town. This region is considered the third-largest tech innovation hub globally, after the Bay Area and Beijing. The firm aims to address the underinvestment at the breakout and scale-up stages in this area. Their strategy is designed to build a comprehensive pipeline that supports companies from early stages through to public offerings, ensuring continuous growth and development. Phoenix Court Works, the philanthropic arm of the group, supports local community initiatives in health, education, and environmental sustainability by allocating 10% of the management company’s profits and 2% of carry from all funds. This initiative has supported 23 organizations to date, focusing on improving health and wellbeing, promoting education and inclusion, and addressing climate and environmental issues.

PhotonDelta, based in Eindhoven, Netherlands, is a leading accelerator in the integrated photonics industry. Founded in 2018, the organization plays a crucial role in building Europe's photonics ecosystem by fostering startups and scale-ups that are developing photonic integrated circuits (PICs). These circuits are essential for innovations across various sectors, including healthcare, telecommunications, and autonomous vehicles. PhotonDelta's strategy is centered around a long-term vision to establish the Netherlands as a global leader in photonics. The organization has secured over €1.1 billion in public and private investments to support its mission. This funding is used to scale up production, support the creation of 200 startups, and build infrastructure and talent across Europe by 2030. PhotonDelta also recently launched PhotonVentures, a €60 million venture capital fund aimed at early-stage photonic chip companies, with plans to expand the fund to €150 million. PhotonDelta's ecosystem includes 70 organizations, offering a complete value chain from design to manufacturing. Their efforts extend globally, as evidenced by the opening of an office in California to enhance collaboration between European and North American photonics industries.

Picus Capital, founded in 2015 and headquartered in Munich, Germany, is an early-stage venture capital firm with a long-term investment philosophy. The firm focuses on technology-driven sectors such as financial services, HR, energy & climate, healthcare, logistics & mobility, real estate & construction, crypto & web3, deep tech, and e-commerce. Picus Capital has made significant investments in companies like Ledge, Spot My Energy, Cove Living, Poolit, and Alasco, among others. Their portfolio spans across 20+ countries with a diverse range of startups that are innovating in their respective fields. The firm's unique approach emphasizes close partnerships with their portfolio companies, assisting them with strategic decisions and operational challenges. With offices in Munich, London, New York, Beijing, and other key locations, Picus Capital is well-positioned to support global growth and expansion. The firm is led by co-founders Robin Godenrath, Alexander Samwer, and Jeremias Heinrich, who bring extensive experience and a strong entrepreneurial mindset to the table. Their team is dedicated to helping daring technology companies build successful, global enterprises that challenge the status quo and shape the future​

Pinto Ventures AG is a Swiss seed-stage venture capital and company-building firm founded in 2019 and headquartered in Walchwil in the canton of Zug. The firm is structured as a single-LP fund and is led by Founder Joao Monteiro, formerly VP of New Business at global logistics giant Kuehne + Nagel. Pinto focuses on angel and pre-seed to seed investments in founders building across fintech, logistics technology, healthtech, and retail, with a deliberate geographic concentration on Europe. Check sizes range from approximately $250,000 to $5 million. Pinto Ventures has made roughly 15 investments over its history, and two portfolio companies have been acquired: Monese, a UK challenger bank, and VONZU, a SaaS delivery-management platform. Other notable portfolio investments include eTEU (maritime and logistics software), Roundabout (marketplace), and XYB (financial software). Co-investors across Pinto's deals include Kinnevik, PayPal, Speedinvest, Global Founders Capital, HSBC, Investec, Cavalry Ventures, and Axa Venture Partners — demonstrating strong alignment with top-tier European and global VCs. Pinto positions itself as a capital-plus-craft investor: bringing time, capital, and access together in equal measure. The firm offers hands-on collaborative support to founders via impactful introductions across key business areas and operates with what it calls 'skin in the game' — its own principals are actively engaged in the commercial development of each portfolio company rather than serving purely in a board-oversight capacity. The team of two partners keeps the portfolio concentrated and ensures close attention to each founder relationship.

Pioneers Ventures is a pre-seed investment fund established in 2015 as part of a collaboration between Pioneers and Speedinvest. The fund focuses on investing in early-stage startups across various sectors, including Business Tech, Consumer Tech, Fintech, and Health Tech. Following a restructuring, Pioneers Ventures continues to operate under the startup300 umbrella, which offers a broad range of services including financial support, networking, and corporate collaboration opportunities. Pioneers Ventures stands out by not only providing capital but also offering extensive support through business scaling consulting, access to a global network of corporate and public sector partners, and guaranteed publicity. They also provide co-founding opportunities and consulting in business model development, aiming to help startups grow from the ground up. The firm has a diverse portfolio of investments that include innovative companies such as Blockpit (cryptocurrency compliance), Fretello (AI-based guitar learning), and Mooci (a digital network for aesthetic medicine). Additionally, Pioneers offers a "Venture Clienting" service, which helps corporations collaborate with startups to innovate and develop new solutions​.

Pitango Venture Capital, established in 1993 and based in Herzliya, Israel, is one of the largest and most prominent venture capital firms in Israel, managing over $3 billion across various funds. The firm focuses on investing in early-stage startups through Pitango First, growth-stage companies through Pitango Growth, and health tech innovations through Pitango HealthTech. Pitango has backed a range of notable companies that have become leaders in their respective fields. These include Via Transportation, which has revolutionized urban mobility, Taboola, a significant player in content recommendation and discovery, and Varonis Systems, a cybersecurity company. The firm has also been involved in successful exits, such as the acquisition of Anobit by Apple and the IPO of Radware on NASDAQ. The investment strategy of Pitango emphasizes partnering with visionary entrepreneurs and providing them with the necessary resources and guidance to scale their businesses. The team at Pitango includes experienced professionals like Nechemia (Chemi) Peres and Rami Kalish, who bring a wealth of expertise to the firm’s diverse investment portfolio. Pitango's approach is characterized by a strong commitment to innovation and sustainability, ensuring that the companies they invest in are not only successful but also contribute positively to the broader community. This dedication has positioned Pitango as a key player in both the Israeli and global venture capital ecosystems.

Piton Capital is a venture capital firm based in London, focusing on investments in online businesses with network effects such as marketplaces, exchanges, and platforms. Founded in 2010, Piton Capital leverages their extensive experience to identify and support high-growth companies that benefit from strong network effects, which they believe offer defensibility and potential for dominance in their markets. Their portfolio includes notable investments in companies like DocPlanner, AUTO1.com, and Redbubble. These investments underscore Piton Capital's strategy of backing businesses that can scale rapidly and create significant value through network-driven growth. Piton Capital primarily invests in Europe but extends their reach globally, including regions like the Americas and Asia. They typically lead rounds in the Seed to Series B stages, with an average check size of $1-5 million. Their investment horizon is 3-5 years, focusing on sectors such as fintech, healthcare, and e-commerce. The firm's team includes key partners like Andrin Bachmann, Edouard Mercier, and Helen Clark, who bring a wealth of experience and strategic insight to their investments. They are headquartered in London but also maintain a presence in Amsterdam. Piton Capital prefers to be approached through warm introductions or referrals, emphasizing the importance of a well-articulated vision and a strong business model that leverages network effects. Their active investment strategy and commitment to supporting their portfolio companies make them a valuable partner for ambitious startups aiming for market leadership.

PJ Tech Catalyst is a venture capital fund based in Athens, Greece, established under the JEREMIE EU initiative. The fund focuses on seed-stage investments in the Information and Communication Technology (ICT) sector, aiming to support the development of innovative startups in Greece. With €15 million under management, the fund invests up to €750,000 in promising technology companies, providing both financial backing and strategic guidance to help startups scale and succeed in competitive markets. Since its launch in 2012, PJ Tech Catalyst has invested in 21 startups and supported 40 follow-on financings, making a significant impact on Greece's entrepreneurial ecosystem. The fund emphasizes collaboration with young entrepreneurs and offers support in areas such as product development, financing, and talent acquisition, helping founders to focus on growing their businesses. Key members of the investment committee, including Nikos Antoniou, Vassilis Theoharakis, and Kostas Mallios, bring extensive international experience from companies like Microsoft and Intel, and have deep insights into both the Greek and global tech markets. PJ Tech Catalyst is particularly focused on creating high-value, exportable technology products, aiming to retain local talent and foster innovation within Greece. The fund operates with a mission to turn visionary tech ideas into scalable businesses, contributing to job creation and economic growth in Greece’s strategic ICT sector.

Planet A Ventures, based in Berlin, is a pioneering venture capital fund dedicated to supporting GreenTech startups that drive significant environmental impact. With a first fund of €160 million, Planet A invests primarily in European companies focused on achieving net-zero emissions and promoting sustainability across various sectors including agriculture, energy, manufacturing, and transportation. Notable investments include Makersite, which uses AI to enhance sustainable supply chains, and INERATEC, known for its modular chemical plants producing sustainable fuels. The fund also backs innovative solutions like Wildplastic, which recycles plastic waste, and GA Drilling, which develops geothermal energy technologies. Planet A takes a science-based approach to investing, incorporating life cycle assessments into its due diligence process to ensure each investment's positive impact. This methodology allows their in-house science team to veto investments that don't meet stringent environmental criteria. The fund typically writes initial checks ranging from €500k to €3 million and prefers to lead rounds. Key team members include founders Tobias Seikel, Nick de la Forge, Fridtjof Detzner, Christian Schad, Christoph Gras, and Lena Thiede. Their combined expertise spans investing, entrepreneurship, and environmental science, ensuring a well-rounded support system for portfolio companies. Active engagement with portfolio startups and a commitment to scalable, impactful solutions position Planet A Ventures as a leader in the GreenTech VC space.

Planeteer Capital is a venture capital firm based in New York City that focuses on pre-seed and seed-stage investments in climate tech startups. Founded by Sophie Purdom, a co-founder of Climate Tech VC (CTVC), Planeteer Capital aims to partner with founders who are addressing the challenges of climate change through innovative technologies and solutions. The firm is anchored by an Ivy League endowment and backed by notable investors including Collaborative Fund and former Meta CTO Mike Schroepfer. Planeteer Capital targets sectors such as carbon management, industrial decarbonization, the built environment, climate intelligence and insurance, and sustainable agriculture. The firm’s mission is to empower visionary founders with the necessary capital and network to prove and scale their transformative models. Planeteer Capital distinguishes itself by providing not just financial support, but also strategic guidance and a sophisticated understanding of the climate tech capital stack​​.

Play Ventures is the leading early-stage gaming venture capital firm, founded in 2018 by former gaming entrepreneurs Henric Suuronen and Harri Manninen. The firm operates from headquarters in Singapore, with a second office in Helsinki, Finland, and invests globally. Play's thesis is grounded in a straightforward observation: gaming is the largest form of entertainment at over $200 billion annually — more than twice the combined value of music and film — and gaming mechanics are increasingly powering a new generation of consumer applications beyond traditional games. The firm leads rounds across pre-seed, seed, and Series A in mobile free-to-play games, mobile consumer apps, gaming infrastructure, AI-enhanced tools, and gaming-adjacent SaaS. Play Ventures has raised three funds: Fund I at $30 million (2018), Fund II at $135 million (2021), and Fund III at $140 million (2024) — its largest to date, bringing total AUM to approximately $450 million. As of late 2025, the firm has made 126 investments, delivering 1 unicorn, 1 IPO, and 12 acquisitions. Notable portfolio wins include MPL (Indian gaming unicorn), Huuuge Games, Futureplay Games, Eloelo (live social entertainment with over 90 million users and 150,000 creators), and Reworks (acquired by Playtika for $400 million plus a $200 million earn-out). Recent investments include Cypher Games ($30 million Series A co-led with The Raine Group) and Ray Browser ($6.5 million). Play Ventures takes an active role in each portfolio company, leveraging the founders' own operational backgrounds in gaming to provide substantive guidance on game design, monetization, and distribution strategy. The firm's global footprint across Singapore, Helsinki, and active deal-making in India and the United States gives portfolio companies direct access to the markets and talent pools where gaming growth is concentrated.

Pleiade Venture is a French venture capital firm founded in 1999 and based in Paris, with a satellite office at Euratechnologies in Lille — investing across the whole of French territory. Pleiade is part of the Pleiade Investissement platform and positions itself as 'the Entrepreneurs' fund': it is exclusively financed by entrepreneurs who, drawing on their own operational experience, actively contribute to the development of portfolio companies through long-term investment without a fixed exit horizon. The firm manages over EUR 100 million in assets under management and has made 74 investments over its history. Partners include Jean-Michel Renck, Laurent Vernier, Maximilien Oursel, and Constance Rietzler. Pleiade invests from the first funding round through Series A in innovative French companies experiencing accelerating growth, across every sector except biotech and life sciences. Typical checks run EUR 0.3 million to EUR 3 million per transaction, with equity commitments up to EUR 5 million over the life of an investment. The firm has delivered 11 portfolio exits to date; most recent include askR.ai (exit on 26 May 2025) and ArcaScience (Series A investment on 3 September 2025 in business productivity software). Pleiade's defining characteristic is its LP composition: because all capital comes from entrepreneurs rather than institutional sources, the firm can offer portfolio founders a genuine peer network and avoid the exit-horizon pressures that shape traditional fund timelines. This structure lets Pleiade operate as a patient, long-term partner — backing companies through multiple development stages without forcing premature liquidity events. The firm's geographic concentration within France allows its team to maintain close proximity to founders across the entire investment lifecycle.

Plug and Play Ventures is the venture capital and accelerator arm of Plug and Play Tech Center, one of the world's largest innovation platforms, headquartered in Sunnyvale, California and founded in 2006 by Saeed Amidi. The firm's origins trace to Amidi's family property at 165 University Avenue in Palo Alto, where he and partner Pejman Nozad informally backed building tenants including Google and PayPal. Amidi recycled those returns to open the Plug and Play Tech Center in Sunnyvale — a 150,000-square-foot facility that became the nucleus of a global innovation network now spanning 30-plus locations across five continents, 400-plus corporate partners, and 400-plus VC partners. The firm is technology-agnostic and invests at pre-seed and seed with typical checks of $100,000 to $150,000. Over 19 years, Plug and Play has made more than 2,370 investments — an average of 78 new investments per year in the last decade. The portfolio includes 39 unicorns: among them Dropbox, PayPal, LendingClub, N26, Honey, Guardant Health, Rappi, Hippo, and Zero Hash (which reached unicorn status in 2025). The firm has also produced 24 public listings, including BitGo (NYSE IPO in January 2026 at a $1.92 billion valuation). Sector programs span fintech, health, insurtech, IoT, mobility, sustainability, and agtech. Plug and Play's model pairs early capital with structured acceleration: startups gain access to a curated network of Fortune 500 corporate partners and downstream VCs through 15-plus industry-specific programs running simultaneously. The firm's scale creates a rare compounding advantage — a startup accepted into one program gains credibility, customer introductions, and investor exposure that would otherwise require years to assemble independently.

Plural is a European early-stage venture capital platform founded by a group of experienced entrepreneurs and operators, including Taavet Hinrikus (co-founder of Wise), Ian Hogarth, Khaled Helioui, and Sten Tamkivi. Launched in 2022, Plural was created to address the need for more founder-led VC firms in Europe, inspired by the success of similar models in Silicon Valley. With a €250 million fund and a recently expanded €400 million fund, Plural aims to support startups that are tackling some of the most challenging and impactful problems in sectors like deep tech, AI, and biotech. The platform focuses on backing "non-obvious, hard" companies—those working on complex, mission-driven projects where the experience and guidance of seasoned founders can significantly tilt the odds in their favor. Plural's investment philosophy centers on the belief that Europe's technological leadership is crucial for shaping global standards and values. The firm emphasizes scalability and inclusivity, with a strong network of peers committed to giving back to the next generation of builders. This approach is designed to create companies that not only succeed but have a GDP-level impact on Europe’s economy​.

Point Nine Capital, headquartered in Berlin, is a prominent early-stage venture capital firm that focuses primarily on SaaS, enterprise software, and B2B marketplaces. Since its inception in 2008, the firm has made significant investments in companies like Algolia, Chainalysis, Contentful, Delivery Hero, Docplanner, Loom, and Zendesk​. Point Nine typically invests at the seed stage, with initial ticket sizes ranging from €500,000 to €5 million. They also occasionally participate in pre-seed, "Seed II", and early Series A rounds. The firm is geographically agnostic, with about 20-30% of its investments based outside of Europe, particularly in the US, Canada, and other regions​​. The firm's investment strategy emphasizes deep involvement with portfolio companies, helping them scale and succeed. Over 65% of Point Nine's seed-stage investments progress to Series A, and more than ten companies in their portfolio have reached $100 million+ in annual recurring revenue​. Notable team members include co-founders Christoph Janz, Carsten Thoma, and Ciarán O’Leary. The firm operates with a strong commitment to support and nurture startups through various stages of their growth​​. Point Nine's track record of successful investments and their strategic support system makes them a key player in the early-stage venture capital landscape, driving growth and innovation across the tech ecosystem.

Polaris Partners, a venture capital firm established in 1996 and headquartered in Boston, Massachusetts, has a distinguished history of investing in transformative healthcare and biotechnology companies. With over 400 companies funded, more than 100 exits, and 50 IPOs, Polaris Partners has solidified its position as a leading investor in the industry​​. The firm's portfolio is diverse, including notable companies such as Ironwood Pharmaceuticals, JibJab Media, LegalZoom, and Living Proof. Polaris Partners focuses primarily on healthcare, life sciences, and biotechnology sectors, targeting innovative care delivery models, digital health solutions, patient and provider platforms, and data science and analytics​ ​. Polaris Partners operates multiple funds, including the Polaris Growth Fund, which supports the expansion of profitable, founder-owned technology companies, and the Polaris Innovation Fund, aimed at accelerating the commercial and therapeutic potential of early-stage academic research​​. Key team members include Brian Chee, Bryce Youngren, and Alexandra Cantley, who bring extensive expertise and leadership to the firm's investment strategies. Polaris Partners prides itself on being more than just investors—they are builders and connectors with a deep network of syndicate partners, universities, and research institutions​​. For entrepreneurs, Polaris Partners offers robust support, leveraging their decades of experience and comprehensive network to help companies achieve successful outcomes and bring innovative therapies to market.